Literature DB >> 23638214

Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury.

Angeliki Xagorari1, Eleni Siotou, Minas Yiangou, Eleftheria Tsolaki, Dimitris Bougiouklis, Leonidas Sakkas, Athanassios Fassas, Achilles Anagnostopoulos.   

Abstract

The aim of this study was to investigate the role of Mesenchymal Stem Cell (MSC) conditioned medium (CM(MSC)) on apoptosis of cultured mouse primary hepatocytes after in vivo carbon tetrachloride (CCl4)-induced acute liver injury. The acute liver injury was induced by injecting CCl4 intraperitoneally in C57/BL6 mice. Hepatocytes were isolated by liver perfusion, cultured in a defined medium to maintain their differentiation and characterized by reverse transcriptase polymerase chain reaction (RT-PCR) using the hepatic cell specific genes albumin, hepatocyte nuclear factor 4 (HNF4) and cytokeratin 18 (CK18). CM(MSC) was generated from cultured bone marrow-derived MSCs (BM-MSCs). BM-MSCs were positive for CD73, CD90, CD44 by flow cytometry and able to differentiate into chondrocytes, adipocytes and osteocytes. Apoptosis was evaluated by both annexin V. CM(MSC) were examined by flow cytometry to detect MSC-derived annexin V- and CD54/CD44-positive microparticles (MPs). In the CCl4-CM(MSC) treated hepatocytes, interleukin-6 (IL-6) was increased on the first day of culture compared to control and CCl4 and was followed by upregulation of fibroblast-like-protein (FGL1) expression after 48 hrs. This was associated with a significant decrease of annexin V positive CCl4-CM(MSC) treated hepatocytes at day 3 post plating. Recombinant IL-6 was induced FGL1 expression in hepatocytes derived from CCl4-treated mice suggesting that CM(MSC), which is enriched also in microparticles, attenuates CCl4-induced early apoptosis in hepatocytes through activation of FGL1.

Entities:  

Keywords:  FGL1; Hepatic cell apoptosis; IL-6; mesenchymal stem cell-conditioned medium; microparticles

Mesh:

Substances:

Year:  2013        PMID: 23638214      PMCID: PMC3638093     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  31 in total

1.  CCl4-induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression.

Authors:  Toshiyuki Otsuka; Hitoshi Takagi; Norio Horiguchi; Mitsuo Toyoda; Ken Sato; Hisashi Takayama; Masatomo Mori
Journal:  FEBS Lett       Date:  2002-12-18       Impact factor: 4.124

Review 2.  The role of microvesicles in tissue repair.

Authors:  Ciro Tetta; Stefania Bruno; Valentina Fonsato; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

3.  Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.

Authors:  K Kovalovich; W Li; R DeAngelis; L E Greenbaum; G Ciliberto; R Taub
Journal:  J Biol Chem       Date:  2001-05-10       Impact factor: 5.157

4.  Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure.

Authors:  Chang-Yan Li; Chuan-Zeng Cao; Wang-Xiang Xu; Meng-Meng Cao; Fan Yang; Lan Dong; Miao Yu; Yi-Qun Zhan; Ya-Bing Gao; Wei Li; Zhi-Dong Wang; Chang-Hui Ge; Qing-Ming Wang; Rui-Yun Peng; Xiao-Ming Yang
Journal:  Gut       Date:  2009-11-01       Impact factor: 23.059

5.  Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice.

Authors:  Julia I Leu; Mary Ann S Crissey; Rebecca Taub
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

6.  Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts.

Authors:  Keith D Salazar; Susan M Lankford; Arnold R Brody
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-04       Impact factor: 5.464

7.  Cloning and characterization of a mouse liver-specific gene mfrep-1, up-regulated in liver regeneration.

Authors:  Jun Yan; Hao Ying; Fei Gu; Jin He; Yu Li Li; Hui Min Liu; Yong Hua Xu
Journal:  Cell Res       Date:  2002-12       Impact factor: 25.617

8.  Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration.

Authors:  Torsten Wuestefeld; Christian Klein; Konrad L Streetz; Ulrich Betz; Jörg Lauber; Jan Buer; Michael P Manns; Werner Müller; Christian Trautwein
Journal:  J Biol Chem       Date:  2002-12-30       Impact factor: 5.157

9.  Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs.

Authors:  Tian Sheng Chen; Ruenn Chai Lai; May May Lee; Andre Boon Hwa Choo; Chuen Neng Lee; Sai Kiang Lim
Journal:  Nucleic Acids Res       Date:  2009-10-22       Impact factor: 16.971

10.  Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats.

Authors:  M B Herrera; V Fonsato; S Gatti; M C Deregibus; A Sordi; D Cantarella; R Calogero; B Bussolati; C Tetta; G Camussi
Journal:  J Cell Mol Med       Date:  2009-07-24       Impact factor: 5.310

View more
  35 in total

1.  Bone marrow-derived mesenchymal stem cells inhibits hepatocyte apoptosis after acute liver injury.

Authors:  Yijing Cai; Zhuolin Zou; Liyuan Liu; Si Chen; Yi Chen; Zhuo Lin; Keqing Shi; Lanman Xu; Yongping Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Therapeutic potential of Bama miniature pig adipose stem cells induced hepatocytes in a mouse model with acute liver failure.

Authors:  Shuang Zhang; Zhiqiang Zhu; Yufeng Wang; Shi Liu; Chenqiong Zhao; Weijun Guan; Yuhua Zhao
Journal:  Cytotechnology       Date:  2018-03-07       Impact factor: 2.058

3.  Therapeutic effects of mesenchymal stem cells-conditioned medium derived from suspension cultivation or silymarin on liver failure mice.

Authors:  Sedigheh Molaei; Fatemeh Amiri; Rasoul Salimi; Shirin Ferdowsi; Marzie Bahadori
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

Review 4.  Mesenchymal stromal cells: promising treatment for liver cirrhosis.

Authors:  Lichao Yao; Xue Hu; Kai Dai; Mengqin Yuan; Pingji Liu; Qiuling Zhang; Yingan Jiang
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

Review 5.  Stem cell-based regenerative opportunities for the liver: State of the art and beyond.

Authors:  Eleftheria Tsolaki; Evangelia Yannaki
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

6.  Role of Human Wharton's Jelly Derived Mesenchymal Stem Cells (WJ-MSCs) for Rescue of d-Galactosamine Induced Acute Liver Injury in Mice.

Authors:  Raghu Ramanathan; Secunda Rupert; Sakthivel Selvaraj; Jeswanth Satyanesan; Rosy Vennila; Surendran Rajagopal
Journal:  J Clin Exp Hepatol       Date:  2017-04-01

Review 7.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

8.  CXCL14 and MCP1 are potent trophic factors associated with cell migration and angiogenesis leading to higher regenerative potential of dental pulp side population cells.

Authors:  Y Hayashi; M Murakami; R Kawamura; R Ishizaka; O Fukuta; M Nakashima
Journal:  Stem Cell Res Ther       Date:  2015-05-29       Impact factor: 6.832

9.  SDF-1/CXCR4 Axis Promotes MSCs to Repair Liver Injury Partially through Trans-Differentiation and Fusion with Hepatocytes.

Authors:  Ning-Bo Hao; Chang-Zhu Li; Mu-Han Lü; Bo Tang; Su-Min Wang; Yu-Yun Wu; Guang-Ping Liang; Shi-Ming Yang
Journal:  Stem Cells Int       Date:  2015-08-02       Impact factor: 5.443

Review 10.  Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies.

Authors:  Naomi D'souza; Filippo Rossignoli; Giulia Golinelli; Giulia Grisendi; Carlotta Spano; Olivia Candini; Satoru Osturu; Fabio Catani; Paolo Paolucci; Edwin M Horwitz; Massimo Dominici
Journal:  BMC Med       Date:  2015-08-12       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.